Impaired FANCD2 monoubiquitination and hypersensitivity to camptothecin uniquely characterize Fanconi anemia complementation group M

Blood

Volumn 114, Issue 1, 2009, Pages 174-180

  Singh, Thiyam Ramsing ^a   Bakker, Sietske T ^b,c   Agarwal, Sheba ^b   Jansen, Michael ^a   Grassman, Elke ^a   Godthelp, Barbara C ^d   Ali, Abdullah Mahmood ^a   Du, Chang Hu ^a   Rooimans, Martin A ^b   Fan, Qiang ^a   Wahengbam, Kebola ^a   Steltenpool, Jurgen ^b   Andreassen, Paul R ^a   Williams, David A ^a   Joenje, Hans ^b   De Winter, Johan P ^b   Meetei, Amom Ruhikanta ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c NETHERLANDS CANCER INSTITUTE   (Netherlands)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; CAMPTOTHECIN; FANCONI ANEMIA COMPLEMENTATION GROUP M PROTEIN; FANCONI ANEMIA GROUP A PROTEIN; FANCONI ANEMIA GROUP D2 PROTEIN; FANCONI ANEMIA PROTEIN; MITOMYCIN C; UNCLASSIFIED DRUG; CROSS LINKING REAGENT; FANCA PROTEIN, HUMAN; FANCD2 PROTEIN, HUMAN; FANCM PROTEIN, HUMAN; HELICASE; RECOMBINANT PROTEIN;

ALLELE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL LINE; CELL SUBPOPULATION; CHEMOSENSITIVITY; CONTROLLED STUDY; CROSS LINKING; FANCONI ANEMIA; GENE DELETION; GENE FUNCTION; GENE LOCATION; GENE MUTATION; HUMAN; HUMAN CELL; LYMPHOBLAST; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; RADIOSENSITIVITY; UBIQUITINATION; ULTRAVIOLET RADIATION; DRUG RESISTANCE; GENE EXPRESSION; GENETIC TRANSFECTION; GENETICS; METABOLISM; MUTATION; PHYSIOLOGY; RADIATION DOSE; TUMOR CELL LINE;

ADENOSINE TRIPHOSPHATASES; CAMPTOTHECIN; CELL LINE, TUMOR; CROSS-LINKING REAGENTS; DNA HELICASES; DRUG RESISTANCE; FANCONI ANEMIA; FANCONI ANEMIA COMPLEMENTATION GROUP A PROTEIN; FANCONI ANEMIA COMPLEMENTATION GROUP D2 PROTEIN; GENE EXPRESSION; HUMANS; MUTATION; RADIATION TOLERANCE; RECOMBINANT PROTEINS; TRANSFECTION; UBIQUITINATION; ULTRAVIOLET RAYS;

EID: 67650569540     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-02-207811     Document Type: Article

References (33)

1. Wang W. Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins. Nat Rev Genet. 2007;8:735-748. (Pubitemid 47429206)
2. de Winter JP, Joenje H. The genetic and molecular basis of Fanconi anemia. Mutat Res. Prepublished on November 14, 2008, as DOI 10.1016/j.mrfmmm.2008.11.004.
3. Meetei A, de Winter J, Medhurst A, et al. A novel ubiquitin ligase is deficient in Fanconi anemia. Nat Genet. 2003;35:165-170. (Pubitemid 37187635)
4. Machida YJ, Machida Y, Chen Y, et al. UBE2T is the E2 in the Fanconi anemia pathway and undergoes negative autoregulation. Mol Cell. 2006; 23:589-596. (Pubitemid 44205488)
5. Alpi A, Langevin F, Mosedale G, Machida YJ, Dutta A, Patel KJ. UBE2T, the Fanconi anemia core complex, and FANCD2 are recruited independently to chromatin: a basis for the regulation of FANCD2 monoubiquitination. Mol Cell Biol. 2007;27:8421-8430.
6. Ishiai M, Kitao H, Smogorzewska A, et al. FANCI phosphorylation functions as a molecular switch to turn on the Fanconi anemia pathway. Nat Struct Mol Biol. 2008;15:1138-1146.
7. Kim JM, Kee Y, Gurtan A, D'Andrea AD. Cell cycle-dependent chromatin loading of the Fanconi anemia core complex by FANCM/FAAP24. Blood. 2008;111:5215-5222.
8. Taniguchi T, Garcia-Higuera I, Andreassen PR, Gregory RC, Grompe M, D'Andrea AD. S-phase-specific interaction of the Fanconi anemia protein, FANCD2, with BRCA1 and RAD51. Blood. 2002; 100:2414-2420.
9. Smogorzewska A, Matsuoka S, Vinciguerra P, et al. Identification of the FANCI protein, a mono-ubiquitinated FANCD2 paralog required for DNA repair. Cell. 2007;129:289-301. (Pubitemid 46584733)
10. Howlett NG, Taniguchi T, Olson S, et al. Biallelic inactivation of BRCA2 in Fanconi anemia. Science. 2002;297:606-609. (Pubitemid 34815345)
11. Levitus M, Waisfisz Q, Godthelp BC, et al. The DNA helicase BRIP1 is defective in Fanconi anemia complementation group. J Nat Genet. 2005; 37:934-935.
12. Levran O, Attwooll C, Henry RT, et al. The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia. Nat Genet. 2005;37:931-933. (Pubitemid 43086147)
13. Reid S, Schindler D, Hanenberg H, et al. Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer. Nat Genet. 2007;39:162-164. (Pubitemid 46184345)
14. Xia B, Dorsman JC, Ameziane N, et al. Fanconi anemia is associated with a defect in the BRCA2 partner PALB2. Nat Genet. 2007;39:159-161. (Pubitemid 46184344)
15. Meetei AR, Medhurst AL, Ling C, et al. A human ortholog of archaeal DNA repair protein Hef is defective in Fanconi anemia complementation group M. Nat Genet. 2005;37:958-963. (Pubitemid 43086152)
16. Mosedale G, Niedzwiedz W, Alpi A, et al. The vertebrate Hef ortholog is a component of the Fanconi anemia tumor-suppressor pathway. Nat Struct Mol Biol. 2005;12:763-771. (Pubitemid 43086250)
17. Banerjee S, Smith S, Oum J-H, et al. Mph1 promotes gross chromosomal rearrangements through partial inhibition of homologous recombination. J Cell Biol. 2008;181:1083-1093. (Pubitemid 351915484)
18. Sun W, Nandi S, Osman F, et al. The FANCM ortholog Fml1 promotes recombination at stalled replication forks and limits crossing over during DNA double-strand break repair. Mol Cell. 2008; 32:118-128.
19. Prakash R, Satory D, Dray E, et al. Yeast Mph1 helicase dissociates Rad51-made D-loops: implications for crossover control in mitotic recombination. Genes Dev. 2009;23:67-79.
20. Komori K, Hidaka M, Horiuchi T, Fujikane R, Shinagawa H, Ishino Y. Cooperation of the N-terminal helicase and C-terminal endonuclease activities of archaeal Hef protein in processing stalled replication forks. J Biol Chem. 2004;279: 53175-53185. (Pubitemid 40051820)
21. Prakash R, Krejci L, Van Komen S, Schürer KA, Kramer W, Sung P. Saccharomyces cerevisiae MPH1 gene, required for homologous recombination- mediated mutation avoidance, encodes a 3′ to 5′DNA helicase. J Biol Chem. 2005;280:7854-7860.
22. Gari K, Décaillet C, Stasiak AZ, Stasiak A, Constantinou A. The Fanconi anemia protein FANCM can promote branch migration of Holliday junctions and replication forks. Mol Cell. 2008;29: 141-148.
23. Gari K, Décaillet C, Delannoy M, Wu L, Constantinou A. Remodeling of DNA replication structures by the branch point translocase FANCM. Proc Natl Acad Sci U S A. 2008;105: 16107-16112.
24. Meetei AR, Sechi S, Wallisch M, et al. A multiprotein nuclear complex connects Fanconi anemia and Bloom syndrome. Mol Cell Biol. 2003;23: 3417-3426. (Pubitemid 36539175)
25. Joenje H, Lo ten Foe JR, Oostra AB, et al. Classification of Fanconi anemia patients by complementation analysis: evidence for a fifth genetic subtype. Blood. 1995;86:2156-2160.
26. Chandra S, Levran O, Jurickova I, et al. A rapid method for retrovirus-mediated identification of complementation groups in Fanconi anemia patients. Mol Ther. 2005;12:976-984. (Pubitemid 41614494)
27. Kupfer G, Naf D, Garcia-Higuera I, et al. A patient-derived mutant form of the Fanconi anemia protein, FANCA, is defective in nuclear accumulation. Exp Hematol. 1999;27:587-593. (Pubitemid 29181434)
28. Medhurst AL, Laghmani EH, Steltenpool J, et al. Evidence for subcomplexes in the Fanconi anemia pathway. Blood. 2006;108:2072-2080. (Pubitemid 44395023)
29. Lo Ten Foe JR, Rooimans MA, Bosnoyan-Collins L, et al. Expression cloning of a cDNA for the major Fanconi anaemia gene, FAA. Nat Genet. 1996;14:320-323.
30. Ameziane N, Errami A, Léveillé F, et al. Genetic subtyping of Fanconi anemia by comprehensive mutation screening. Hum Mutat. 2008;29:159-166.
31. Xue Y, Li Y, Guo R, Ling C, Wang W. FANCM of the Fanconi anemia core complex is required for both monoubiquitination and DNA repair. Hum Mol Genet. 2008;17:1641-1652. (Pubitemid 351737168)
32. Ciccia A, Ling C, Coulthard R, et al. Identification of FAAP24, a Fanconi anemia core complex protein that interacts with FANCM. Mol Cell. 2007; 25:331-343. (Pubitemid 46206138)
33. Godthelp BC, Wiegant WW, Waisfisz Q, et al. Inducibility of nuclear Rad51 foci after DNA damage distinguishes all Fanconi anemia complementation groups from D1/BRCA2. Mutat Res. 2006;594:39-48.